Align Technology, Inc.

ALGN Healthcare Medical Instruments & Supplies

Align Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 0.90% from fiscal 2024.

Revenue
+1.92%
EPS
+143.9%
Free cash flow
+8.26%

Quarter to September 2026, against a year earlier

160.79 1.42 +0.89%
Market cap
$11.3B
P/E
23.1×
Fwd P/E
20.4×
Dividend yield
—
F-score
6/9
Altman Z
4.73
Beneish M
−2.52
Dividend safety
n/a
Older periods Dec '25 Mar '26 Jun '26 Sep '26
P/E ratio

+8 more quarters

27.59 28.72 29.28 21.12
P/S ratio
2.81 2.99 2.91 2.48
P/FCF ratio
23.08 20.98 17.85 15.41
P/Operating CF
50.76 81.07 62.56 56.41
P/B ratio
2.80 2.95 2.85 2.44
EV/Sales
2.54 2.73 2.65 2.21
EV/EBITDA
13.07 13.78 13.66 11.44
EV/FCF
20.85 19.16 16.22 13.70
Current Ratio
1.36 1.39 1.40 1.42
Net Debt/EBITDA
(4.26) (5.34) (5.68) 0.00
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
3.62% 3.48% 3.42% 4.73%
Free Cash Flow Yield
4.33% 4.77% 5.60% 6.49%
Free Cash Flow per Share
2.58 1.68 2.78 2.58
Book value per Share
55.82 58.09 59.20 60.65
Free Cash Flow
187.26 120.26 199.09 182.92
EV/EBIT
18.75 20.09 20.01 14.79
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026